- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Balaxi Pharmaceuticals Ltd (BALX)
Balaxi Pharmaceuticals Ltd stock price live, this page displays NSE BALX stock exchange data. View the BALX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Balaxi Pharmaceuticals Ltd real time stock price chart below.
What Is the Balaxi Pharmaceuticals Ltd Stock Price Today?
The Balaxi Pharmaceuticals Ltd stock price today is 45.66.
What Is the Stock Symbol for Balaxi Pharmaceuticals Ltd?
The stock symbol for Balaxi Pharmaceuticals Ltd is ""BALX.""
What Stock Exchange Does Balaxi Pharmaceuticals Ltd Trade On?
Balaxi Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Balaxi Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Balaxi Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BALX quote. (ISIN: INE618N01022)
What Is the Balaxi Pharmaceuticals Ltd Stock Price Today?
The Balaxi Pharmaceuticals Ltd stock price today is 45.66.
What Is the Stock Symbol for Balaxi Pharmaceuticals Ltd?
The stock symbol for Balaxi Pharmaceuticals Ltd is ""BALX.""
What Stock Exchange Does Balaxi Pharmaceuticals Ltd Trade On?
Balaxi Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Balaxi Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Balaxi Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BALX quote. (ISIN: INE618N01022)
NSE
Currency in INR
45.66
-1.21(-2.58%)
Closed·
Fair Value
An estimate of a Balaxi Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.50
47.19
52 wk Range
42.56
127.45
BALX Scorecard
Full Analysis
Trading at a low Price / Book multiple
BALX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Balaxi Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.5047.19
52 wk Range
42.56127.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BALX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Balaxi Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Balaxi Pharmaceuticals Ltd Company Profile
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
Compare BALX to Peers and Sector
Metrics to compare | BALX | Peers Peers - average of corresponding metrics from companies closely matching BALX: ASTERDM, MAITREYA, 536565, KRSNAA, INDRAMEDCO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBALXPeersSector |
|---|---|---|---|---|
P/E Ratio | 13.7x | 46.2x | −0.6x | |
PEG Ratio | −0.23 | 0.25 | 0.00 | |
Price/Book | 1.1x | 5.8x | 2.6x | |
Price / LTM Sales | 0.9x | 3.4x | 3.3x | |
Upside (Analyst Target) | - | 30.2% | 39.0% | |
Fair Value Upside | Unlock | 1.6% | 4.9% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
1.56 / --
Revenue / Forecast
745.73M / --
People Also Watch
FAQ
What Stock Exchange Does Balaxi Pharmaceuticals Trade On?
Balaxi Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Balaxi Pharmaceuticals?
The stock symbol for Balaxi Pharmaceuticals is "BALX."
What Is the Balaxi Pharmaceuticals Market Cap?
As of today, Balaxi Pharmaceuticals market cap is 2.52B.
What Is Balaxi Pharmaceuticals's Earnings Per Share (TTM)?
The Balaxi Pharmaceuticals EPS (TTM) is 3.42.
From a Technical Analysis Perspective, Is BALX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Balaxi Pharmaceuticals Stock Split?
Balaxi Pharmaceuticals has split 1 times.
How Many Employees Does Balaxi Pharmaceuticals Have?
Balaxi Pharmaceuticals has 600 employees.
What is the current trading status of Balaxi Pharmaceuticals (BALX)?
As of 26 Aug 2025, Balaxi Pharmaceuticals (BALX) is trading at a price of 45.66, with a previous close of 46.87. The stock has fluctuated within a day range of 45.50 to 47.19, while its 52-week range spans from 42.56 to 127.45.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.